ArticleThe Lancet regional health. Western Pacific2026
Cardiovascular magnetic resonance-based arrhythmogenic substrate assessment improves sudden cardiac death risk stratification in heart failure with mildly reduced ejection fraction: a multicenter retrospective observational study.
Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The risk stratification of sudden cardiac death (SCD) in patients with heart failure (HF) with mildly reduced ejection fraction (HFmrEF) remains suboptimal. This study aims to evaluate the role of late gadolinium enhancement (LGE) and T1 mapping in predicting SCD in patients with HFmrEF and to provide an improved clinical risk stratification algorithm. Methods: A total of 1855 patients with HFmrEF from five tertiary medical centers were enrolled in this study, all of whom underwent echocardiography and cardiovascular magnetic resonance (CMR). Data analysis utilized a multicenter development cohort (n = 1417) and a multicenter external validation cohort (n = 438). The primary endpoints were sudden cardiac death, appropriate ICD shocks, and resuscitated cardiac arrest. Secondary endpoints were a composite of HF death, unplanned HF hospitalization, or cardiac transplantation. Based on validated MRI predictors, a risk algorithm and corresponding clinical workflow were developed for SCD risk assessment. Findings: During a median follow-up of 42 months in the development cohort, 142 and 140 patients experienced primary and secondary endpoints, respectively. Adjusted analyses identified the following as significant predictors of SCD-related events: LGE ≥6.3% (HR 5.33, 95% CI: 3.74-7.60; P < 0.001), ECV ≥28.4% (HR 3.44, 95% CI: 2.32-5.11; P < 0.001), and a native T1 z-score ≥2.7 (HR 2.40, 95% CI 1.67-3.48; P < 0.001). Patients with ECV >28.4% and no LGE showed higher SCD risk compared to those with ECV <28.4% and LGE <6.3% or mid-wall LGE. Conversely, patients with ln (NT-proBNP) <6.2, LGE <6.3%, and ECV <28.4% had a lower SCD risk, with an annual event rate of 0.4%. Notably, LGE ≥6.3% was associated with a high annual SCD event rate of 7.9%, irrespective of ECV, NT-proBNP levels, and LGE distribution. Interpretation: In HFmrEF, at least 6.3% of LGE serves as a strong predictor of SCD risk, irrespective of its distribution. ECV significantly enhances risk stratification, particularly in patients with negative or mid-wall LGE. Funding: This study was supported by the National Natural Science Foundation of China (Grant Nos. 81871354, 81571672) and Key R&D Program of Shandong Province, China (2025CXPT106, 2025CXGC020305).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.